Anticancer stem cell therapy: Gremlin-1 (GREM1) increases the expression of oncomiR miRNA-17-92 via down regulation of its target gene, 7/May/2015, 23.01

Small molecule-based Lifespan extension therapy: B lymphocyte-induced maturation protein-1 inhibits senescence and extends life span by down regulating the expression of adenylate cyclase 5 (ADCY5), 7/May/2015, 15.34
May 7, 2015
Regenerative Stem cell therapy for Myocardial Infarction: FRA1 improves myocardial function after myocardial infarction via up regulation of PNUTS/PPP1R10 (Serine/threonine-protein phosphatase 1 regulatory subunit 10), 07/May/2015, 23.08
May 7, 2015
Show all

A recent study from the Gastrointestinal Stem Cell Biology Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK; Translational Gastroenterology Unit, Experimental Medicine Division,,  shows that “Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside the stem cell niche.” This study was published in the 1 December 2014 issue of the Journal “Nature Medicine” [the number 1 journal in General medicine with an impact factor of 24.973] by Prof. Leedham SJ and others.

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Anticancer stem cell therapy: Gremlin-1 (GREM1) increases the expression of oncomiR miRNA-17-92 via down regulation of its target gene. This study suggests, for the first time, Gremlin-1, by decreasing the expression of its target gene BMP4, it may : (1) increase the expression of miRNA-17-92; (2) decrease the expression of a number of tumor suppressor genes; and (3) promote cancer stem cell prolifertion and selfrenewal. Thus, pharmacological formulations encompassing Gremlin-1 inhibitors” may be used to inhibit cancer stem cell proliferation and self-renewal. 

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan,  Anticancer stem cell therapy: Gremlin-1 (GREM1) increases the expression of oncomiR miRNA-17-92 via down regulation of its target gene, 7/May/2015,  23.01,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Undisclosed information: How Gremlin-1 increases the expression of oncomiR miRNA-17-92

Comments are closed.